Discovery and Heterologous Expression of Microginins from Microcystis aeruginosa LEGE 91341

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Nádia Eusébio - , Universidade do Porto (Autor:in)
  • Raquel Castelo-Branco - , Universidade do Porto (Autor:in)
  • Diana Sousa - , Universidade do Porto (Autor:in)
  • Marco Preto - , Universidade do Porto (Autor:in)
  • Paul D'agostino - , Professur für Technische Biochemie, Technische Universität Dresden (Autor:in)
  • Tobias A.M. Gulder - , Professur für Technische Biochemie, Technische Universität Dresden (Autor:in)
  • Pedro N. Leaõ - , Universidade do Porto (Autor:in)

Abstract

Microginins are a large family of cyanobacterial lipopeptide protease inhibitors. A hybrid polyketide synthase/non-ribosomal peptide synthetase biosynthetic gene cluster (BGC) found in several microginin-producing strains mic was proposed to encode the production of microginins, based on bioinformatic analysis. Here, we explored a cyanobacterium, Microcystis aeruginosa LEGE 91341, which contains a mic BGC, to discover 12 new microginin variants. The new compounds contain uncommon amino acids, namely, homophenylalanine (Hphe), homotyrosine (Htyr), or methylproline, as well as a 3-aminodecanoic acid (Ada) residue, which in some variants was chlorinated at its terminal methyl group. We have used direct pathway cloning (DiPaC) to heterologously express the mic BGC from M. aeruginosa LEGE 91341 in Escherichia coli, which led to the production of several microginins. This proved that the mic BGC is, in fact, responsible for the biosynthesis of microginins and paves the way to accessing new variants from (meta)genome data or through pathway engineering.

Details

OriginalspracheEnglisch
Seiten (von - bis)3493-3503
Seitenumfang11
FachzeitschriftACS synthetic biology
Jahrgang11
Ausgabenummer10
PublikationsstatusVeröffentlicht - 21 Okt. 2022
Peer-Review-StatusJa

Externe IDs

PubMed 36166626

Schlagworte

Schlagwörter

  • biosynthesis, cyanobacteria, direct pathway cloning (DiPaC), heterologous expression, microginins, natural products